{"id":15107,"date":"2022-05-11T08:18:49","date_gmt":"2022-05-11T06:18:49","guid":{"rendered":"https:\/\/ggba.swiss\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/"},"modified":"2023-07-04T13:40:33","modified_gmt":"2023-07-04T11:40:33","slug":"eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/","title":{"rendered":"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device"},"content":{"rendered":"\n<p>Vaud-based start-up <a href=\"https:\/\/limula.ch\/\" target=\"_blank\" rel=\"noopener\">Limula<\/a> and Valais-based medtech <a href=\"https:\/\/ceidos.com\/\" target=\"_blank\" rel=\"noopener\">CEIDOS<\/a> have received a grant of EUR 1.14 million from Innosuisse, through the <a href=\"https:\/\/www.innosuisse.ch\/inno\/en\/home\/promotion-of-international-projects\/eurostars.html\" target=\"_blank\" rel=\"noopener\">Eurostars<\/a> initiative, to develop a platform dedicated to the automated production of cell and gene therapy products.<\/p>\n<p>Chimeric antigen receptor (CAR) T-cell therapies have shown exceptional clinical efficacy for the treatment of multiple forms of incurable cancers. However, most eligible patients may never receive these life-saving treatments as there are still significant hurdles in manufacturing these therapies at scale.<\/p>\n<p>Limula\u00a0is offering an automated technology for end-to-end production of CAR-T cell therapies that allows for carrying out all steps of the manufacturing process in a single self-contained device. The solution can potentially change the manufacturing paradigm and make these life-changing solutions at accessible costs while minimizing any manual interventions required.<\/p>\n<p>A joint project aims to augment Limula\u2019s solution by leveraging technology and expertise from two companies,\u00a0CEIDOS\u00a0and\u00a0<a href=\"https:\/\/www.stemmatters.com\/\" target=\"_blank\" rel=\"noopener\">Stemmatters<\/a>.<\/p>\n<p>CEIDOS develops C-NETICS, an automated system for continuously monitoring cell density and viability in a non-destructive way. C-NETICS comprises a single-use cartridge that allows cell counting and characterization using microelectrodes and image analysis using an embedded digital microscope. Artificial Intelligence is used to extract rich information from real-time data.<\/p>\n<p>Based in Portugal, Stemmmaters is a private regenerative medicine company providing contract development and manufacturing services for cell-based products and biologics.<\/p>\n<h4>A perfect synergy of skills for the benefit of technological innovation<\/h4>\n<p>Highlighting the perfect synergy of skills between the cantons of Vaud and Valais for the benefit of technological innovation in biopharma, the project will combine Limula and CEIDOS\u2019 closed-loop real-time cell culture monitoring into a complementary product offering, while also leveraging Stemmatters\u2019s expertise in cell therapy process development and cGMP manufacturing towards fully closed and automated manufacturing of cell-based immunotherapies.<\/p>\n<p>The proof-of-concept financed by the Eurostars\u2019 EUR 1.14 million grant will demonstrate the value of a modular platform, addressing the needs of organizations involved in developing new CGT products, from preclinical research to commercialization.<\/p>\n<p>Beyond the collaboration, Limula will be responsible for the commercialization of the integrated technology to deliver a scalable and cost-effective manufacturing platform as soon as possible to help bring more CGT products into the clinic for the benefit of patients.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the automated production of cell and gene therapy products.<\/p>\n","protected":false},"author":3,"featured_media":15108,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[912,926,911],"class_list":["post-15107","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-biotech","tag-medtech","tag-pharma"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the automated production of cell and gene therapy products.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-11T06:18:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:40:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device\",\"datePublished\":\"2022-05-11T06:18:49+00:00\",\"dateModified\":\"2023-07-04T11:40:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/\"},\"wordCount\":374,\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png\",\"keywords\":[\"Biotech\",\"Medtech\",\"Pharma\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/\",\"name\":\"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png\",\"datePublished\":\"2022-05-11T06:18:49+00:00\",\"dateModified\":\"2023-07-04T11:40:33+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/","og_locale":"en_US","og_type":"article","og_title":"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device - Greater Geneva Bern area","og_description":"In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the automated production of cell and gene therapy products.","og_url":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2022-05-11T06:18:49+00:00","article_modified_time":"2023-07-04T11:40:33+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png","type":"image\/png"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mathieu","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#article","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device","datePublished":"2022-05-11T06:18:49+00:00","dateModified":"2023-07-04T11:40:33+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/"},"wordCount":374,"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png","keywords":["Biotech","Medtech","Pharma"],"articleSection":["Life sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/","url":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/","name":"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#primaryimage"},"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png","datePublished":"2022-05-11T06:18:49+00:00","dateModified":"2023-07-04T11:40:33+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/CEIDOS-630x380-1-3.png","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/staging.ggba.swiss\/en\/eurostars-grants-ceidos-and-limula-eur-1-14-million-for-an-innovative-device\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/en\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/15107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=15107"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/15107\/revisions"}],"predecessor-version":[{"id":17148,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/15107\/revisions\/17148"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/15108"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=15107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=15107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=15107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}